Vericel Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Hello, everyone. Good morning. My name is Raphael Taubenfeld. I'm a member of the Healthcare Investment Banking team here at JPMorgan. Welcome to the final day of the Virtual JPMorgan Healthcare Conference.
We have the pleasure here with us today to have Nick Colangelo, President and CEO of Vericel here with us. We'll be going through the presentation in a moment. (Operator Instructions)
And with that, I'll hand it over to Nick.
Well, thank you, Raphael. It is great to be here today, and we really appreciate the opportunity to present for the first time at the JPMorgan conference. And before I begin, I'll just remind those in attendance that this presentation contains forward-looking statements, so you should refer to our documents on file with the SEC for further information.
So starting at Slide 3. Vericel is a leader in advanced therapies for the sports medicine and the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |